Nipro Corporation
↗Osaka, Japan
Nipro Corporation is a leading global healthcare company headquartered in Osaka, Japan. Founded in 1954, the company has evolved from a glass manufacturer into a comprehensive medical giant operating across three primary segments: Medical Devices, Pharmaceuticals, and Pharma Packaging. Nipro is world-renowned for its renal care products, holding the second-largest global market share for dialyzers.
The company's pharmaceutical division focuses on generic drugs and innovative 'kit' products, such as pre-filled syringes and dual-chamber bags, designed to enhance safety and efficiency in clinical settings. Nipro is also a major Contract Development and Manufacturing Organization (CDMO) for global pharma partners and is increasingly investing in regenerative medicine and biosimilars.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Renal Care, Generics, and Pharma Packaging
SIZE & FINANCIALS
Employees:10000+
Revenue:$3.5B - $4.5B
Founded:1954
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:The Master Trust Bank of Japan, Nippon Electric Glass Co., Ltd., Custody Bank of Japan
STOCK
Exchange:Tokyo Stock Exchange
Ticker:8086
Market Cap:~$1.5B - $2.0B USD (fluctuating with JPY exchange rate)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Stemirac for Spinal Cord Injury)
Modalities:Small molecule, Biosimilars, Cell therapy, Medical Devices
Active Trials:15
Trial Phases:Phase 1: 2 | Phase 2: 3 | Phase 3: 5 | Phase 4: 5
FDA Approvals:50
EMA Approvals:40
CORPORATE STRUCTURE
Subsidiaries:Nipro Pharma Corporation, Nipro Medical Corporation (USA), Nipro Europe Group, PT Nipro Indonesia Jaya
Key Partnerships:Samsung Bioepis (Biosimilar commercialization in Japan), Sapporo Medical University (Regenerative medicine development)
COMPETITION
Position:Leader
Competitors:Fresenius Medical Care, Baxter International, B. Braun, Terumo Corporation, Gerresheimer (Packaging)
LEADERSHIP
Key Executives:
Yoshihiko Sano - Chairperson and Representative Director
Tsuyoshi Yamazaki - President and Representative Director
Board Members:Yoshiko Tanaka (Outside Director), Toshiaki Hattori, Kenichi Nishida
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Nipro Corporation. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.